Menlo Park's Intersect ENT latest health/bio IPO to lower target
July 14, 2014 at 10:29 AM EDT
Nasal implant maker Intersect ENT is the latest in the health and biotech sector to lower its IPO targets, setting price targets to raise up to $74...